Literature DB >> 9120494

Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo.

V L Stevenson1, M L Gawne-Cain, G J Barker, A J Thompson, D H Miller.   

Abstract

Recent reports have suggested that fluid attenuated inversion recovery (FLAIR) is a technique superior to conventional (CSE) or fast spin echo (FSE) T2-weighted sequences in detecting intrinsic lesions both in the brain and spinal cord. We report our experience of an inversion recovery prepared FSE, which we refer to as fast FLAIR, in a comparative study of ten patients with clinically definite multiple sclerosis (MS) who underwent cervical cord and brain imaging with both FSE and fast FLAIR. The results showed that in the cerebral hemispheres fast FLAIR detected more lesions than FSE (P < 0.001). However, FSE detected more lesions than fast FLAIR in the posterior fossa (P = 0.02) and in the cord fast FLAIR was much inferior detecting only 2 of 33 lesions seen on FSE. Estimating the T2 relaxation times of lesions in each of three areas (periventricular, posterior fossa, cervical cord) showed that the T2 value of posterior fossa and cervical cord lesions was significantly lower than that of periventricular lesions, suggesting that the lesion composition is different and consequently their imaging appearances are different. In conclusion, although fast FLAIR improves the detection of MS lesions in the cerebral hemispheres, its substantially lower sensitivity in the posterior fossa and spinal cord is a potentially important limitation to its use as a tool for the diagnosis of MS and for monitoring therapies. Further studies are needed to elucidate the mechanisms underlying the loss of sensitivity.

Entities:  

Mesh:

Year:  1997        PMID: 9120494     DOI: 10.1007/s004150050060

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images.

Authors:  D M Moriarty; A J Blackshaw; P R Talbot; H L Griffiths; J S Snowden; V F Hillier; S Capener; R D Laitt; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

2.  Neuroradiological evaluation of demyelinating disease.

Authors:  Jan-Mendelt Tillema; Istvan Pirko
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

Review 3.  Magnetic resonance imaging of intramedullary spinal cord tumors.

Authors:  G M Lowe
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

4.  Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination.

Authors:  J I O'Riordan; N A Losseff; C Phatouros; A J Thompson; I F Moseley; D G MacManus; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

5.  Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.

Authors:  Arzu Ozturk; Nafi Aygun; Seth A Smith; Brian Caffo; Peter A Calabresi; Daniel S Reich
Journal:  Neuroradiology       Date:  2012-12-04       Impact factor: 2.804

6.  Normal findings on brain fluid-attenuated inversion recovery MR images at 3T.

Authors:  M Neema; Z D Guss; J M Stankiewicz; A Arora; B C Healy; R Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-15       Impact factor: 3.825

7.  A comparison of MR imaging with fast-FLAIR, HASTE-FLAIR, and EPI-FLAIR sequences in the assessment of patients with multiple sclerosis.

Authors:  M Filippi; M A Rocca; M Wiessmann; S Mennea; M Cercignani; T A Yousry; M P Sormani; G Comi
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

8.  Fluid-Attenuated Inversion Recovery Hyperintense Ischemic Stroke Predicts Less Favorable 90-Day Outcome after Intravenous Thrombolysis.

Authors:  Yongwoo Kim; Marie Luby; Nina-Serena Burkett; Gina Norato; Richard Leigh; Clinton B Wright; Kyle C Kern; Amie W Hsia; John K Lynch; Malik M Adil; Lawrence L Latour
Journal:  Cerebrovasc Dis       Date:  2021-07-20       Impact factor: 3.104

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.